EX-99.1
Published on July 26, 2010
Exhibit 99.1
1 Becton Drive
Franklin Lakes, NJ 07417
www.bd.com
Franklin Lakes, NJ 07417
www.bd.com
| News Release |  |
Contact:
Colleen T. White, Corporate Communications 201-847-5369
Sherry Bertner, Investor Relations 201-847-5453
Colleen T. White, Corporate Communications 201-847-5369
Sherry Bertner, Investor Relations 201-847-5453
BD Board of Directors Elects Christopher Jones
Franklin Lakes, NJ (July 26, 2010) BD (Becton, Dickinson and Company) (NYSE:BDX), a
leading global medical technology company, announced today that it has elected Christopher
Jones to its Board of Directors, effective today.
Mr. Jones, 55, is the former Chief Executive Officer of JWT Worldwide (previously known as J.
Walter Thompson), one of the worlds largest advertising agencies. He retired from JWT Worldwide in
2001 after 24 years of distinguished service at the firm, including leading its U.K. business and
serving as President of Global Clients prior to being appointed CEO.
We are honored to welcome Chris Jones to the BD Board, said Edward J. Ludwig, BD Chairman and Chief
Executive Officer. Chris brings to the Board unique global expertise and perspective developed
through his extensive and diverse international business experiences. He is also a seasoned
global marketing expert who will offer valuable insight as BD expands its business into growing and
emerging markets.
Mr. Jones is currently an active leader in many business and not-for-profit organizations. He
serves as Operating Partner, outside director and member of the Adjudications Committee at Cognetas
LLP, a pan-European private equity firm. He is also a director of Central Trust PLC, a British
financial services firm, and the non-executive Chairman of Results International Group, a leading
corporate finance and strategy advisor to the global marketing communications industry.
In the healthcare arena, Mr. Jones chairs the board of The Pavilion Clinic, which provides
diagnostic services in the U.K., and is a board member and advisor to the musculo-skeletal surgical
group at the Oxford Clinic. He has also been a member of the Health Advisory Board at the Johns
Hopkins Bloomberg School of Public Health since 1997.
Mr. Jones is a Trustee and member of the Executive Committee at the International Institute for
Strategic Studies, Chairman of the Governors at the Dragon School and a Governor of St. Edwards
School.
Mr. Jones is a graduate of Cambridge University in the U.K.
With his election, the BD board will consist of 14 members, all of whom are independent with the
exception of Mr. Ludwig.
About BD
BD is a leading global medical technology company that develops, manufactures and sells medical
devices, instrument systems and reagents. The Company is dedicated to improving peoples health
throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of
diagnosing infectious diseases and cancers, and advancing research, discovery and production of new
drugs and vaccines. BDs capabilities are instrumental in combating many of the worlds most
pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs
approximately 29,000 associates in more than 50 countries throughout the world. The Company serves
healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical
industry and the general public. For more information, please visit www.bd.com.
***